Effect of Sintilimab combined with Chemotherapy on Tumor Markers and Immune Function of advanced non-small cell lung cancer

OBJECTIVE: To evaluate the effect of sintilimab combined with chemotherapy on tumor markers and immune function in advanced non-small cell lung cancer. METHODS: The study was conducted at Xi’an Medical University, China. The 120 patients with advanced NSCLC who were treated in our hospital from Janu...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Xiaoyan, Wei, Zhangfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281194/
https://www.ncbi.nlm.nih.gov/pubmed/34290784
http://dx.doi.org/10.12669/pjms.37.4.3820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281194/
https://www.ncbi.nlm.nih.gov/pubmed/34290784
http://dx.doi.org/10.12669/pjms.37.4.3820

Ejemplares similares